Transverse Myelitis Trial, Recruiting (NCT06541626)

Transverse Myelitis Trial, Recruiting NCT06541626 Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Condition: Transverse Myelitis

Printed from Voxsanity (voxsanity.com.au) — NCT06541626 — Data sourced from ClinicalTrials.gov. Verify directly with the trial site before attending. Not medical advice.

Back to Transverse Myelitis

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

You are between 18 and 65 years old and have been diagnosed with an inflammatory disease affecting the myelin (protective coating) of your brain or spinal cord
Your condition has been identified as one of the following: MS (Multiple Sclerosis), NMOSD, MOGAD, ADEM, clinically isolated syndrome, demyelinating encephalopathy, demyelinating myelitis, or brainstem encephalitis (confirm with trial site if unsure which applies to you)
You are willing to take part in the study and are able to sign a consent form agreeing to participate

Who may not be able to join:

You have a history of cancer or have been diagnosed with a tumor in the brain or spinal cord
You have an infection affecting your brain or spinal cord
Your myelin damage is caused by a genetic condition, a metabolic disorder, poisoning/toxic exposure, a blood vessel problem, or a physical injury rather than inflammation
You are unlikely or unable to follow the treatment plan and attend the required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.

Last synced 28 July 2026

This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Phone: 86+13824498978

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Voxsanity

Clinical trials and treatments, explained plainly · voxsanity.com.au

Date:

To: My Doctor

Re: Clinical trial enquiry

I am writing to enquire about the following clinical trial which may be relevant to my care:

Trial: NCT06541626

Sponsor: Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Phase: Not Applicable

Status: Recruiting

Condition: Transverse Myelitis

Trial contact: 86+13824498978

More information: https://clinicaltrials.gov/study/NCT06541626

Eligibility summary (AI generated)

Written by an AI model from ClinicalTrials.gov eligibility criteria and checked on a sample basis. Please confirm against the original criteria.

Who might be able to join this trial:

You are between 18 and 65 years old and have been diagnosed with an inflammatory disease affecting the myelin (protective coating) of your brain or spinal cord
Your condition has been identified as one of the following: MS (Multiple Sclerosis), NMOSD, MOGAD, ADEM, clinically isolated syndrome, demyelinating encephalopathy, demyelinating myelitis, or brainstem encephalitis (confirm with trial site if unsure which applies to you)
You are willing to take part in the study and are able to sign a consent form agreeing to participate

Who may not be able to join:

You have a history of cancer or have been diagnosed with a tumor in the brain or spinal cord
You have an infection affecting your brain or spinal cord
Your myelin damage is caused by a genetic condition, a metabolic disorder, poisoning/toxic exposure, a blood vessel problem, or a physical injury rather than inflammation
You are unlikely or unable to follow the treatment plan and attend the required follow-up appointments

Important: Always verify eligibility with the trial site directly before applying.

Access in Australia: A treatment being studied in a clinical trial is generally not yet listed on the PBS. Where a medicine is not approved or not available through a trial, the TGA Special Access Scheme may allow a doctor to access unapproved therapeutic goods for individual patients. See voxsanity.com.au/sas-navigator/ for a plain English explainer.

This information was sourced from ClinicalTrials.gov via Voxsanity (data last synced 28 July 2026). It is not medical advice. Please verify the trial's current status directly with the trial site before acting.

Trial details

Status

Recruiting

Phase

Not Applicable

Sponsor

Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

Registry

ClinicalTrials.gov

Start date

1 January 2024

Est. completion

31 December 2035

Where this trial is recruiting

🇨🇳 China

Primary endpoints

Relapse; Long-term neurological function

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov